Compositions containing adenosine triphosphate (ATP) and methods of use
The present invention provides a composition comprising adenosine or adenosine triphosphate (ATP) acting as an absorption enhancer when combined with a nutritional material(s) such as nutrients, protein, peptides, vitamins, phytochemicals, minerals, fatty acids, or amino acids or a drug. Methods of administering ATP or adenosine to improve the bioavailability of a nutritional material(s) such as nutrients, protein, peptides, vitamins, phytochemicals, minerals, fatty acids, or amino acids or a drug are described.
1. A method for increasing the bioavailability of a nutritional material in an animal comprising administering enterally to the animal at least one nutritional material containing at least one amino acid comprising glutamine, asparagine, alanine, arginine, and/or citrulline; and an effective dosage of an absorption enhancer, wherein the absorption enhancer is adenosine triphosphate (ATP) or adenosine.
2. The method of claim 1 , wherein the nutritional material contains at least one of protein, peptides, and/or individual amino acids.
3. A method for improving the absorption of a nutritional material in a human, comprising administering enterally to the human an effective dosage of an absorption enhancer, wherein the absorption enhancer is adenosine triphosphate (ATP) or adenosine; and at least one nutritional material containing at least one amino acid comprising glutamine, asparagine, alanine, arginine, and/or citrulline.
4. The method of claim 3 , wherein the nutritional material contains at least one of protein, peptides, and/or individual amino acids.
5. The method of claim 4 , wherein the nutritional material contains additional amino acids.
6. The method of claim 5 , wherein the additional amino acids are essential amino acids.
7. The method of claim 5 , wherein the additional amino acids are branched chain amino acids.
8. A method for improving the bioavailability of at least one vitamin in an animal, comprising administering enterally to the animal at least one vitamin and an effective dosage of an absorption enhancer for at least fifteen days, wherein the absorption enhancer is adenosine triphosphate (ATP) or adenosine.
9. The method of claim 8 , wherein the improved bioavailability is measured as a greater increase in blood serum levels of the vitamin as compared to administration of the vitamin without the absorption enhancer.
10. The method of claim 8 , wherein the vitamin is Vitamin K.